Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis - PubMed (original) (raw)
Comparative Study
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis
Peter Panizzi et al. J Am Coll Cardiol. 2010.
Abstract
Objectives: The aim of this study was to test whether blood monocytosis in mice with atherosclerosis affects infarct healing.
Background: Monocytes are cellular protagonists of tissue repair, and their specific subtypes regulate the healing program after myocardial infarction (MI). Inflammatory Ly-6C(hi) monocytes dominate on Day 1 to Day 4 and digest damaged tissue; reparative Ly-6C(lo) monocytes dominate on Day 5 to Day 10 and promote angiogenesis and scar formation. However, the monocyte repertoire is disturbed in atherosclerotic mice: Ly-6C(hi) monocytes expand selectively, which might disrupt the resolution of inflammation.
Methods: Ex vivo analysis of infarcts included flow cytometric monocyte enumeration, immunoactive staining, and quantitative polymerase chain reaction. To relate inflammatory activity to left ventricular remodeling, we used a combination of noninvasive fluorescence molecular tomography (FMT-CT) and physiologic imaging (magnetic resonance imaging).
Results: Five-day-old infarcts showed >10x more Ly-6C(hi) monocytes in atherosclerotic (apoE(-/-)) mice compared with wild-type mice. The injured tissue in apoE(-/-) mice also showed a more pronounced inflammatory gene expression profile (e.g., increased tumor necrosis factor-alpha and myeloperoxidase and decreased transforming growth factor-beta) and a higher abundance of proteases, which are associated with the activity of Ly-6C(hi) monocytes. The FMT-CT on Day 5 after MI showed higher proteolysis and phagocytosis in infarcts of atherosclerotic mice. Serial magnetic resonance imaging showed accelerated deterioration of ejection fraction between Day 1 and Day 21 after MI in apoE(-/-). Finally, we could recapitulate these features in wild-type mice with artificially induced Ly-6C(hi) monocytosis.
Conclusions: Ly-6C(hi) monocytosis disturbs resolution of inflammation in murine infarcts and consequently enhances left ventricular remodeling. These findings position monocyte subsets as potential therapeutic targets to augment tissue repair after infarction and to prevent post-MI heart failure.
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Disclosures: Ralph Weissleder and Peter Waterman own shares of VisEn Medical.
Figures
Figure 1
Experimental protocol for ex (A, C) and in vivo (B, D) studies. MI: myocardial infarction induced by coronary ligation, FRI: ex vivo Fluorescence Reflectance Imaging, FACS: Fluorescence Activated Cell Sorting, PCR: Polymerase Chain Reaction-based gen expression profiling, IHC: Immunohistochemistry, DE MRI: delayed enhancement MRI for infarct size measurement.
Figure 2
(A) Original flow cytometry dot plots of blood and infarct tissue in wild type and apoE-/- mice 5 days after coronary ligation. (B) Enumeration of cells shows significantly increased blood and tissue levels for inflammatory Ly-6Chi monocytes in apoE-/- mice.
Figure 3
(A) Immunoreactive staining and quantitation for the presence of the imaging target protease Cathepsin B and F4/80 positive macrophages. Furthermore, presence of MMP2, MMP9, VEGF and CD31 was profiled. Magnification 200×, the scale bar denotes 100 μm. (B) Quantitative RT-PCR: higher expression of MAC-3 and CD68 corroborate in vivo and ex vivo findings of increased cell recruitment into the infarct of apoE-/-. Transcription of MPO and TNF-α is higher in apoE-/- mice, whereas TGF-β is reduced. As a control, we determined apoE, which was undetectable in apoE-/- mice. *p<0.05, **p<0.001.
Figure 4
Image fusion. (A) Multimodal imaging cartridge. (B-E) FMT-CT phantom imaging. (B-C) Coronal CT and FMT-CT. (D) Maximum intensity projection of fused FMT-CT. The well inside the phantom is filled with fluorochrome VT-680 and in addition contains iodine CT contrast. (E) Correlation between CT and FMT-CT dimensions shows good agreement of fused data. (F-K) CT, FMT and FMT-CT in a mouse with MI injected with CLIO. Arrows denote fiducial landmarks used for fusion.
Figure 5
(A) FMT-CT 5 days after MI. Arrows denote apical infarct, arrowhead denotes calcification, presumably in an atherosclerotic lesion. On 3D Prosense and CLIO FMT-CT images, arrows point towards infarct signal. Arrowheads denote fluorescence signal in the carotid artery. (B) Ex vivo fluorescence reflectance imaging corroborates in vivo FMT findings. TBR: target to background ratio. *p<0.05.
Figure 6
Serial cardiac MRI. Initial assessment of infarct size by delayed enhancement after injection of Gd-DTPA (arrows) showed similar values in both groups. Over time, ventricular dilatation was enhanced in apoE-/- mice, which resulted in significantly worse EF on day 21 after MI. *p<0.05.
Figure 7
(A) Flow cytometry on day 5 and serial imaging in wild type mice in which blood monocytosis was induced by LPS. Blood monocytosis led to sustained monocyte presence in the infarct on day 5, increased protease and phagocytic signal on FMT and accelerated left ventricular dilation. (B) ApoE-/- mice in which neutrophils were depleted with injections of anti-Ly-6G antibody show similar inflammation in the infarct by FMT-CT and remodeling by MRI. *p<0.05.
Comment in
- When monocytes come (too) close to our hearts.
Cardilo-Reis L, Witztum JL, Binder CJ. Cardilo-Reis L, et al. J Am Coll Cardiol. 2010 Apr 13;55(15):1639-41. doi: 10.1016/j.jacc.2009.11.068. J Am Coll Cardiol. 2010. PMID: 20378084 No abstract available.
Similar articles
- When monocytes come (too) close to our hearts.
Cardilo-Reis L, Witztum JL, Binder CJ. Cardilo-Reis L, et al. J Am Coll Cardiol. 2010 Apr 13;55(15):1639-41. doi: 10.1016/j.jacc.2009.11.068. J Am Coll Cardiol. 2010. PMID: 20378084 No abstract available. - P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice.
An G, Wang H, Tang R, Yago T, McDaniel JM, McGee S, Huo Y, Xia L. An G, et al. Circulation. 2008 Jun 24;117(25):3227-37. doi: 10.1161/CIRCULATIONAHA.108.771048. Epub 2008 Jun 2. Circulation. 2008. PMID: 18519846 Free PMC article. - The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.
Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. Nahrendorf M, et al. J Exp Med. 2007 Nov 26;204(12):3037-47. doi: 10.1084/jem.20070885. Epub 2007 Nov 19. J Exp Med. 2007. PMID: 18025128 Free PMC article. - Monocytes in myocardial infarction.
Dutta P, Nahrendorf M. Dutta P, et al. Arterioscler Thromb Vasc Biol. 2015 May;35(5):1066-70. doi: 10.1161/ATVBAHA.114.304652. Epub 2015 Mar 19. Arterioscler Thromb Vasc Biol. 2015. PMID: 25792449 Free PMC article. Review. - The Protective Role of TREM2 in the Heterogenous Population of Macrophages during Post-Myocardial Infarction Inflammation.
Kim SH, Lee KY, Chang K. Kim SH, et al. Int J Mol Sci. 2023 Mar 14;24(6):5556. doi: 10.3390/ijms24065556. Int J Mol Sci. 2023. PMID: 36982629 Free PMC article. Review.
Cited by
- Immunometabolism in atherosclerotic disorders.
Fleetwood AJ, Noonan J, La Gruta N, Kallies A, Murphy AJ. Fleetwood AJ, et al. Nat Cardiovasc Res. 2024 Jun;3(6):637-650. doi: 10.1038/s44161-024-00473-5. Epub 2024 May 23. Nat Cardiovasc Res. 2024. PMID: 39196223 Review. - Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches.
Kanuri B, Sreejit G, Biswas P, Murphy AJ, Nagareddy PR. Kanuri B, et al. iScience. 2024 Jun 14;27(7):110274. doi: 10.1016/j.isci.2024.110274. eCollection 2024 Jul 19. iScience. 2024. PMID: 39040061 Free PMC article. Review. - Increased [18F]FDG uptake in the infarcted myocardial area displayed by combined PET/CMR correlates with snRNA-seq-detected inflammatory cell invasion.
Lukovic D, Gyöngyösi M, Pavo IJ, Mester-Tonczar J, Einzinger P, Zlabinger K, Kastner N, Spannbauer A, Traxler D, Pavo N, Goliasch G, Pils D, Jakab A, Szankai Z, Michel-Behnke I, Zhang L, Devaux Y, Graf S, Beitzke D, Winkler J. Lukovic D, et al. Basic Res Cardiol. 2024 Oct;119(5):807-829. doi: 10.1007/s00395-024-01064-y. Epub 2024 Jun 26. Basic Res Cardiol. 2024. PMID: 38922408 Free PMC article. - Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia.
Weinberger T, Denise M, Joppich M, Fischer M, Garcia Rodriguez C, Kumaraswami K, Wimmler V, Ablinger S, Räuber S, Fang J, Liu L, Liu WH, Winterhalter J, Lichti J, Thomas L, Esfandyari D, Percin G, Matin S, Hidalgo A, Waskow C, Engelhardt S, Todica A, Zimmer R, Pridans C, Gomez Perdiguero E, Schulz C. Weinberger T, et al. Elife. 2024 May 22;12:RP89377. doi: 10.7554/eLife.89377. Elife. 2024. PMID: 38775664 Free PMC article. - Loss of developmentally derived Irf8+ macrophages promotes hyperinnervation and arrhythmia in the adult zebrafish heart.
Paquette SE, Oduor CI, Gaulke A, Stefan S, Bronk P, Dafonseca V, Barulin N, Lee C, Carley R, Morrison AR, Choi BR, Bailey JA, Plavicki JS. Paquette SE, et al. bioRxiv [Preprint]. 2024 Apr 20:2024.04.17.589909. doi: 10.1101/2024.04.17.589909. bioRxiv. 2024. PMID: 38659956 Free PMC article. Preprint.
References
- Frangogiannis NG, Entman ML. Targeting the chemokines in myocardial inflammation. Circulation. 2004;110(11):1341–1342. - PubMed
- Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand. 2001;173(1):75–82. - PubMed
- Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 1999;44(2):232–241. - PubMed
- Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res. 2005;66(1):22–32. - PubMed
- Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101(25):2981–2988. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL095612/HL/NHLBI NIH HHS/United States
- R24 CA092782/CA/NCI NIH HHS/United States
- U01 HL080731/HL/NHLBI NIH HHS/United States
- T32 CA079443/CA/NCI NIH HHS/United States
- R01HL096576/HL/NHLBI NIH HHS/United States
- P50 CA086355/CA/NCI NIH HHS/United States
- T32-CA79443/CA/NCI NIH HHS/United States
- P50-CA86355/CA/NCI NIH HHS/United States
- R01 HL095629/HL/NHLBI NIH HHS/United States
- R24 CA092782-05/CA/NCI NIH HHS/United States
- R01-EB006432/EB/NIBIB NIH HHS/United States
- T32 CA079443-08/CA/NCI NIH HHS/United States
- R01 EB006432-04/EB/NIBIB NIH HHS/United States
- R01 AI084880/AI/NIAID NIH HHS/United States
- R00 HL094533/HL/NHLBI NIH HHS/United States
- P50 CA086355-06/CA/NCI NIH HHS/United States
- R01 EB006432/EB/NIBIB NIH HHS/United States
- R01 HL096576/HL/NHLBI NIH HHS/United States
- R01 HL093038/HL/NHLBI NIH HHS/United States
- R24-CA92782/CA/NCI NIH HHS/United States
- UO1-HL-080731/HL/NHLBI NIH HHS/United States
- U01 HL080731-04/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous